Cell-bound complement activation products in systemic lupus erythematosus: Comparison with anti-double-stranded DNA and standard complement measurements

Lupus Science and Medicine

Volumn 1, Issue 1, 2014, Pages

  Putterman, Chaim ^a   Furie, Richard ^b   Ramsey Goldman, Rosalind ^c   Askanase, Anca ^d   Buyon, Jill ^d   Kalunian, Kenneth ^e   Chatham, W Winn ^f   Massarotti, Elena ^g   Kirou, Kyriakos ^h   Jordan, Nicole ^a   Blanco, Irene ^a   Weinstein, Arthur ⁱ   Chitkara, Puja ^j   Manzi, Susan ^k   Ahearn, Joseph ^k   O'Malley, Tyler ^l   Conklin, John ^l   Ibarra, Claudia ^l   Barken, Derren ^l   Dervieux, Thierry ^l  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h HOSPITAL FOR SPECIAL SURGERY   (United States)

ⁱ WASHINGTON HOSPITAL CENTER   (United States)

^j S Diego Arthr Osteoporosis Med C   (United States)

^k ALLEGHENY HEALTH NETWORK   (United States)

^l Exagen Diagnostics Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; CELL BOUND COMPLEMENT ACTIVATION PRODUCT; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; DOUBLE STRANDED DNA ANTIBODY; JO 1 ANTIBODY; LA ANTIBODY; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TURBIDIMETRY;

EID: 84931262384     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2014-000056     Document Type: Article

References (21)

1. Bertsias GK, Pamfil C, Fanouriakis A, et al. Diagnostic criteria for systemic lupus erythematosus: has the time come? Nat Rev Rheumatol 2013;9:687-94.
2. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929-39.
3. Meacock R, Dale N, Harrison MJ. The humanistic and economic burden of systemic lupus erythematosus: A systematic review. Pharmacoeconomics 2013;31:49-61.
4. Gordon C, Isenberg D, Lerstrom K, et al. The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: A European patient-driven online survey. Rheumatology (Oxford) 2013;52:2292-301.
5. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
7. Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012;64:2319-27.
8. Meroni PL, Schur PH. ANA screening: An old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
9. Hanly JG, Thompson K, McCurdy G, et al. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods 2010;352:147-52.
10. Kalunian KC, Chatham WW, Massarotti EM, et al. Measurements of cell bound complement activation products enhance diagnostic performance in systemic lupus erythematosus. Arthritis Rheum 2012;64:4040-7.
11. Manzi S, Navratil JS, Ruffing MJ, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 2004;50:3596-604.
12. Yang DH, Chang DM, Lai JH, et al. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2009;48:1083-7.
13. Ghiran IC, Zeidel ML, Shevkoplyas SS, et al. Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production. Arthritis Rheum 2011;63:503-12.
14. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86.
15. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17-23.
16. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
17. Narain S, Richards HB, Satoh M, et al. DIagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Arch Intern Med 2004;164:2435-41.
18. Alarcon GS, McGwin G Jr, Roseman JM, et al. Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. Arthritis Rheum 2004;51:609-15.
19. Liu CC, Ahearn JM, Manzi S. Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future. Curr Rheumatol Rep 2004;6:85-8.
20. Fritzler MJ, Fritzler ML. The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr Med Chem 2006;13:2503-12.
21. Hanly JG, Su L, Farewell V, et al. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods 2010;358:75-80.